+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antimalarial Drugs Market by Drug Class, Drug Type, Route of Administration, Malaria Type, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Antimalarial Drugs Market by Drug Class, Drug Type, Route of Administration, Malaria Type, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Antimalarial Drugs Market by Drug Class, Drug Type, Route of Administration, Malaria Type, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967662
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antimalarial Drugs Market grew from USD 1.67 billion in 2023 to USD 1.76 billion in 2024. It is expected to continue growing at a CAGR of 5.88%, reaching USD 2.50 billion by 2030.

The antimalarial drugs market, focusing on prevention and treatment of malaria, is influenced by factors such as increasing incidences of malaria, growing awareness about the disease, and investments in healthcare infrastructure. Necessity arises from the burden of malaria in regions like Sub-Saharan Africa and South Asia, requiring effective management and treatment plans. Key applications are in both prophylactic and therapeutic scenarios, aimed at combating Plasmodium falciparum, Plasmodium vivax, and other malaria-causing parasites. The end-use scope spans hospitals, clinics, healthcare facilities, and NGOs focused on global health. Market growth is primarily driven by advancements in drug formulation, supportive government policies, and increased research funding. The development of artemisinin-based combination therapies (ACTs) highlights innovation in this space.

Opportunities lie in the expanding distribution networks in emerging markets and integrating digital technologies for disease tracking and management. Pharmaceutical companies could capitalize on collaborations with research institutions to develop new lines of antimalarials potentially targeting drug-resistant strains, which are a pressing concern. However, challenges include sector limitations due to regulatory hurdles, high costs of research and development, and the prevalence of counterfeit drugs affecting drug efficacy and market trust. Moreover, resistance to existing treatment options poses a significant threat to market sustainability.

To overcome these challenges, emphasis should be placed on investment in R&D for new drug classes, exploring vaccine development, and leveraging AI and big data for advanced analytical predictions and better forecasting of disease outbreaks. Developing cost-effective diagnostic tools and increasing accessibility in high-burden regions will also be critical. In conclusion, while the antimalarial drugs market is ripe with potential for innovation, strategic alliances, enhanced distribution, and technology-driven solutions will be pivotal for sustainable growth and addressing the complex challenges faced in disease mitigation and treatment efficacy.

Understanding Market Dynamics in the Antimalarial Drugs Market

The Antimalarial Drugs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising incidence rates of malaria globally, particularly in tropical and subtropical regions
    • Increasing support from global health organizations for malaria eradication programs
  • Market Restraints
    • Emergence of drug-resistant malaria strains
  • Market Opportunities
    • Collaborations between governments and pharmaceutical companies for increasing penetration of anti-malaria drugs
    • Research and development in drug development and diagnostic tests for malaria
  • Market Challenges
    • Issues related to incorrect dosing, strict compliance, and poor drug quality

Exploring Porter’s Five Forces for the Antimalarial Drugs Market

Porter’s Five Forces framework further strengthens the insights of the Antimalarial Drugs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Antimalarial Drugs Market

External macro-environmental factors deeply influence the performance of the Antimalarial Drugs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Antimalarial Drugs Market

The Antimalarial Drugs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antimalarial Drugs Market

The Antimalarial Drugs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Antimalarial Drugs Market

The Antimalarial Drugs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antimalarial Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alkem Laboratories, Alliance Pharma, Alvizia Health Care, Bayer AG, Cipla Inc., Dr. Reddy's Laboratories, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Glenmark Pharmaceuticals, Hikma Pharmaceuticals PLC, Ipca Laboratories Ltd., Lincoln Pharmaceuticals, Lupin Limited, Merck KGaA, Mylan, Novartis AG, Pfizer Inc., Sanofi Group, Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company, Teva Pharmaceuticals Industries Ltd., Zydus Group, and Zydus Lifesciences Ltd..

Market Segmentation & Coverage

This research report categorizes the Antimalarial Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Drug Class
    • Antifolate compounds
    • Artemisinin compounds
    • Aryl aminoalcohol compounds
    • Endoperoxides
    • Quinoline Methanols
    • Tetracyclines
  • Drug Type
    • Branded
    • Generic
  • Route of Administration
    • Intravenous
    • Oral
  • Malaria Type
    • Plasmodium Falciparum
    • Plasmodium Knowlesi
    • Plasmodium Malariae
    • Plasmodium Ovale
    • Plasmodium Vivax
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • End User
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence rates of malaria globally, particularly in tropical and subtropical regions
5.1.1.2. Increasing support from global health organizations for malaria eradication programs
5.1.2. Restraints
5.1.2.1. Emergence of drug-resistant malaria strains
5.1.3. Opportunities
5.1.3.1. Collaborations between governments and pharmaceutical companies for increasing penetration of anti-malaria drugs
5.1.3.2. Research and development in drug development and diagnostic tests for malaria
5.1.4. Challenges
5.1.4.1. Issues related to incorrect dosing, strict compliance, and poor drug quality
5.2. Market Segmentation Analysis
5.2.1. Drug Class: Widening use of artemisinin compounds owing to its effective results
5.2.2. Malaria Type: Increasing prevalence of plasmodium falciparum
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Antimalarial Drugs Market, by Drug Class
6.1. Introduction
6.2. Antifolate compounds
6.3. Artemisinin compounds
6.4. Aryl aminoalcohol compounds
6.5. Endoperoxides
6.6. Quinoline Methanols
6.7. Tetracyclines
7. Antimalarial Drugs Market, by Drug Type
7.1. Introduction
7.2. Branded
7.3. Generic
8. Antimalarial Drugs Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
9. Antimalarial Drugs Market, by Malaria Type
9.1. Introduction
9.2. Plasmodium Falciparum
9.3. Plasmodium Knowlesi
9.4. Plasmodium Malariae
9.5. Plasmodium Ovale
9.6. Plasmodium Vivax
10. Antimalarial Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Antimalarial Drugs Market, by End User
11.1. Introduction
11.2. Hospitals
11.3. Specialty Clinics
12. Americas Antimalarial Drugs Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Antimalarial Drugs Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Antimalarial Drugs Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Kenya Manufacturer Is First In Africa to Get WHO Approval For Malaria Drug
15.3.2. Fosun Pharma and IFC Partner to Improve Access to High Quality Medicines in Africa
15.3.3. Fosun Pharma Develops Innovative Artemisinin-based Antimalarial Drugs
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ANTIMALARIAL DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ANTIMALARIAL DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. ANTIMALARIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. ANTIMALARIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ANTIMALARIAL DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ANTIMALARIAL DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ANTIFOLATE COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ARTEMISININ COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ARYL AMINOALCOHOL COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ENDOPEROXIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY QUINOLINE METHANOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY PLASMODIUM FALCIPARUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY PLASMODIUM KNOWLESI, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY PLASMODIUM MALARIAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY PLASMODIUM OVALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY PLASMODIUM VIVAX, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIMALARIAL DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 53. CANADA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. CANADA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. CANADA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ANTIMALARIAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. CHINA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. CHINA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 86. CHINA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. CHINA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 88. CHINA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. CHINA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. INDIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. INDIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDIA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. INDIA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDIA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. INDIA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. JAPAN ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 103. JAPAN ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. JAPAN ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 106. JAPAN ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. JAPAN ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. THAILAND ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 139. THAILAND ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. THAILAND ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 142. THAILAND ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. THAILAND ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 158. DENMARK ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. DENMARK ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 161. DENMARK ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. DENMARK ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. EGYPT ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 164. EGYPT ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. EGYPT ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 167. EGYPT ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. EGYPT ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 176. FRANCE ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. FRANCE ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. FRANCE ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. GERMANY ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. ITALY ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 194. ITALY ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. ITALY ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 197. ITALY ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. ITALY ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. POLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 218. POLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. POLAND ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 221. POLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. POLAND ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. QATAR ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 224. QATAR ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 225. QATAR ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. QATAR ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. QATAR ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SPAIN ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 248. SPAIN ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. SPAIN ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 251. SPAIN ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SPAIN ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. TURKEY ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 266. TURKEY ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. TURKEY ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 269. TURKEY ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. TURKEY ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM ANTIMALARIAL DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM ANTIMALARIAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM ANTIMALARIAL DRUGS MARKET SIZE, BY MALARIA TYPE, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM ANTIMALARIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM ANTIMALARIAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. ANTIMALARIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. ANTIMALARIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Antimalarial Drugs Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Alkem Laboratories
  • Alliance Pharma
  • Alvizia Health Care
  • Bayer AG
  • Cipla Inc.
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals
  • Hikma Pharmaceuticals PLC
  • Ipca Laboratories Ltd.
  • Lincoln Pharmaceuticals
  • Lupin Limited
  • Merck KGaA
  • Mylan
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Group
  • Strides Pharma Science Limited
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company
  • Teva Pharmaceuticals Industries Ltd.
  • Zydus Group
  • Zydus Lifesciences Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.76 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.5 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

2024 Global Forecast for Antimalarials, Plasmodicides (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Antimalarials, Plasmodicides (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From
Anti-Malarial Medicines - Global Strategic Business Report - Product Image

Anti-Malarial Medicines - Global Strategic Business Report

  • Report
  • 288 Pages
  • Global
From
Anti-Malarial Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Anti-Malarial Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 102 Pages
  • Global
From
Artemisinic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Artemisinic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
India Antimalarial Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

India Antimalarial Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 87 Pages
  • India
From

About the Antimalarial Market

The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine. In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite. Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.